Chickenpox cases fall 80% over decade: CDC

August 16, 2012 By Margaret Steele, HealthDay Reporter
Chickenpox cases fall 80% over decade: CDC
Two-dose schedule will deliver further improvement, experts say.

(HealthDay) -- Chickenpox cases in the United States dropped almost 80 percent between 2000 and 2010 in 31 states following routine use of the varicella vaccine, the U.S. Centers for Disease Control and Prevention reports.

Updated figures published by the CDC Thursday also show that in the four years after a two-dose vaccine was recommended for children in 2006, cases of declined about 70 percent. The biggest drop occurred in children between the ages of 5 and 9.

"This is one of our success stories," Dr. Charles Shubin, medical director of the Children's Health Center of Mercy FamilyCare in Baltimore, said when earlier figures were released last year.

The number of with adequate chickenpox reporting systems jumped from 12 to 31 between 2000 and 2010, allowing the CDC to better monitor the effectiveness of the vaccine, introduced for routine use in the United States in 1996, the agency said.

In those 31 states reporting, incidence of dropped from 43 cases per 100,000 population in 2000 to nine cases per 100,000 in 2010, the CDC said.

"State reported to CDC are now adequate for monitoring national trends in varicella incidence," the agency said in this week's issue of . But, only with information from all 50 states can health officials paint a complete picture. "Continued strengthening of the and participation from all states is needed to monitor fully the impact of the routine second dose of varicella vaccine," the researchers said.

Symptoms of this common infectious disease include an itchy rash on the face, scalp or trunk, fever and headache. Most cases are mild, lasting five to 10 days, but some people become seriously ill. Adults typically become sicker than children.

In 2010, four chickenpox-related deaths were reported, but none of those were patients known to have had the varicella vaccination, the CDC said.

The CDC recommends that children get two doses of varicella vaccine -- the first dose between 12 and 15 months of age, the second between 4 and 6 years of age or at least three months after the first dose.

Teenagers and adults who have not had chickenpox or the chickenpox vaccine should also get two doses, at least four weeks apart.

Initially, just one dose of vaccine was recommended. As two-dose vaccination increases, the CDC expects to see further declines in chickenpox. While some people may still develop the virus after vaccination, those breakthrough cases tend to be mild, the agency said.

Explore further: Measles-containing vaccines not linked with increased risk of febrile seizures in kids 4-6

More information: To learn more about chickenpox vaccination, see the U.S. Centers for Disease Control and Prevention.


Related Stories

Measles-containing vaccines not linked with increased risk of febrile seizures in kids 4-6

April 2, 2012
Vaccines for measles were not associated with an increased risk of febrile seizures among 4-6 year olds during the six weeks after vaccination, according to a study by the Kaiser Permanente Vaccine Study Center that appears ...

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.